Latest News

Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.

The new Yale center is the first to focus on developing precision medicine for Parkinson’s disease.

For its 20th anniversary, the Kavli Institute is hosting a one-day celebratory symposium. In alignment with our mission, we will highlight subfields of neuroscience: molecular and cellular neuroscience, disease, systems neuroscience, computational neuroscience, and development. This anniversary symposium will feature talks from renowned external speakers, Yale faculty, and Yale trainees. We hope you will celebrate with us during this very special event.

Neuroscience and Cell Biology postdoctoral fellow Sydney Cason, PhD, is one of the 21 Life Science Research Foundation 2024 Awardees.

The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2024 Kavli Postdoctoral Fellowship: Drs. Hongyan Hao, Kevin Chen, and Dhananjay Bhaskar.

This #TraineeTuesday, we are highlighting Chase Amos, a graduate student in the De Camilli Lab! He recently published a report in Contact on the connection between the two proteins VPS13A and XK in red blood cell precursors, and a paper in Molecular Biology of the Cell.

A team of Yale neuroscience researchers sheds light on the early steps of a transport event.

Pietro de Camilli, MD, John Klingenstein Professor of Neuroscience and professor of Cell Biology, was awarded the van Deenen Medal.

In two new papers, scientists provide insight into the function of a protein called VPS13C, one of the molecular suspects that underlie Parkinson’s, a disease marked by uncontrollable movements including tremors, stiffness, and loss of balance.